2021-2022 PDMP Annual Report

Prescription Drug Monitoring Program Annual Report | 2021-22 19 Figure 2. Number of individuals obtaining controlled substance prescriptions from 5(10) or more prescribers and 5(10) or more dispensers by quarter January 2012 – June 2022. Using the data in this performance measure demonstrates the value of the PDMP as a clinical decision-making tool to reduce prescription drug abuse misuse and diversion. One standard definition of MPE is the patient's use of five or more prescribers and five or more pharmacies within three months. Data support that as registration and utilization of the PDMS by prescribers and dispensers increases, the number of MPEs decreases. Proactive reporting of MPEs to registered prescribers and law enforcement agencies and education and outreach activity contributed to initial successes in lowering MPE occurrences. Even though data appear to have plateaued, further decreases have occurred in response to recent program changes, including implementing mandatory utilization EHR integration enhanced PDMS reports and prescriber summary reports. There has been a 6.8 percent decrease in the number of individuals who visited five or more prescribers and five or more pharmacies in a 90-day period compared to FY21, from 456 to 425. OUTCOME 2